Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04790344 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

LUX-Dx TRENDS Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System.

StatusCompleted
PhaseNot applicable
Started2021-03-20
View on ClinicalTrials.gov ↗

Amendment history

The 50 most recent of 63 record versions are accounted for below. See every version on ClinicalTrials.gov ↗

2026-09-01
notable
Study Status, Study Design v62
Trial completed
Study completion confirmed: July 2026 (last estimated November 2026)
Primary completion date2026-07-31→2026-07-27
Completion dateestimated 2026-11→confirmed 2026-07-27
Enrollment targetestimated 525→confirmed 557
2026-08-03
minor
Study Status v61
Primary completion pushed: 2026-07 → 2026-07-31
2026-07-02
minor
Study Status, Contacts/Locations v60
Study sites56→57
2026-06-01
notable
Study Status v59
Primary completion pushed: 2026-05 → 2026-07
Completion pushed: 2026-06 → 2026-11
2026-05-01
minor
19 amendments v40-v58
19 re-verifications since 2024-11-14, no change to tracked fields
Show 27 earlier versions
2024-10-25
minor
Study Status, Contacts/Locations v39
Study sites57→56
2024-09-10
minor
Study Status, Contacts/Locations v38
Study sites60→57
2024-08-01
minor
Study Status, Contacts/Locations v37
Study sites62→60
2024-07-01
minor
Study Status v36
Re-verified, no change to tracked fields
2024-06-03
notable
Recruiting→Active, Not Recruiting Study Status, Contacts/Locations v35
Trial statusRecruiting→Active, Not Recruiting
Study sites76→62
2024-05-07
minor
Study Status, Contacts/Locations v34
Study sites75→76
2024-04-16
minor
Study Status, Contacts/Locations v33
Study sitesdetails revised at 4 of 75 sites
2024-02-16
minor
Study Status v32
Re-verified, no change to tracked fields
2024-01-30
minor
Study Status, Contacts/Locations v31
Study sites76→75
2023-12-07
minor
Study Status, Contacts/Locations v30
Study sitesdetails revised at 5 of 76 sites
2023-11-06
minor
Study Status, Contacts/Locations v29
Study sitesdetails revised at 2 of 76 sites
2023-10-09
minor
Study Status, Contacts/Locations v28
Study sitesdetails revised at 4 of 76 sites
2023-09-18
minor
Study Status, Contacts/Locations v27
Study sitesdetails revised at 2 of 76 sites
2023-08-11
minor
Study Status, Contacts/Locations v26
Study sitesdetails revised at 1 of 76 sites
2023-07-14
minor
Study Status, Contacts/Locations v25
Primary completion date2026-04→2026-05
Completion date2026-05→2026-06
Study sites74→76
2023-06-20
minor
Study Status, Study Design, Contacts/Locations v24
Enrollment target435→525
Study sitesdetails revised at 3 of 74 sites
2023-05-22
minor
Study Status, Contacts/Locations v23
Primary completion date2026-03→2026-04
Study sites60→74
2023-04-24
minor
Study Status, Contacts/Locations v22
Study sites59→60
2023-03-24
minor
Study Status, Contacts/Locations v21
Primary completion date2025-09→2026-03
Completion date2025-10→2026-05
Study sitesdetails revised at 1 of 59 sites
2023-02-23
minor
Study Status, Contacts/Locations v20
Study sites59 entries, revised
Cardiology Associates Research, LLC/North Mississippi Medical Center
2023-01-12
minor
Study Status, Contacts/Locations v19
Study sites58→59
2022-12-05
minor
Study Status, Contacts/Locations v18
Study sites57→58
2022-11-07
minor
Study Status, Contacts/Locations v17
Study sites65→57
2022-10-25
minor
Study Status, Study Design v16
Enrollment target415→435
2022-10-13
minor
Study Status, Contacts/Locations v15
Study sites64→65
2022-09-07
minor
Study Status, Contacts/Locations v14
Study sites63→64
2022-07-18
minor
Study Status, Contacts/Locations v13
Completion date2025-09→2025-10
Study sitesdetails revised at 4 of 63 sites
The primary objective of this study is to collect sensor data from insertable cardiac monitor systems.
Trial Details
NCT Number NCT04790344
Lead Sponsor Boston Scientific Corporation
Conditions Heart Failure
Enrollment 557 participants
Start Date 2021-03-20
Primary Completion 2026-07-27 (estimated)
Study Completion 2026-07-27 (estimated)
Updated on ClinicalTrials.gov 2026-09-03